Position in TARS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,517,600
+$1,833,357 QoQ
Shares Held
40,000
+310.1% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#10
of 60 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TARS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. TARS ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
This page
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in TARS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,517,600 | 40,000 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $684,243 | 9,754 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $724,146 | 8,844 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||